Key result
In diabetic rats, the non-selective NOS inhibitor L-NAME enhanced cumulative urine sodium excretion after volume expansion by 43% (P<0.001), suggesting endothelial NO blunts excretory responses.
p-value: p=<0.001
Endothelial nitric oxide synthase contributes to the blunted renal excretory response to volume expansion in diabetes mellitus, independent of renal innervation.
Does not support clinical changes in diabetic volume management; leaves open endothelial NO targeting and requires human validation.
The renal excretory responses to volume expansion (VE), by 10 % body wt, were determined in groups of anaesthetised streptozotocin-induced diabetic rats with one denervated and one innervated kidney in the presence and absence of nitric oxide synthase (NOS) inhibitors. VE in diabetic rats increased (P < 0.001) cumulative urine sodium excretion (CuU(Na)V) to 104 +/- 9 and 69 +/- 6 micromol min(-1) (g kidney wt)(-1) in the denervated and in the innervated kidneys, respectively, which were both less (P < 0.001) than in the non-diabetic rats, at 225 +/- 14 and 148 +/- 14 micromol min(-1) (g kidney wt)(-1), respectively, in the denervated and the innervated kidney. The non-selective NOS inhibitor, N(G)-nitro-L-arginine-methyl-ester (L-NAME) given to the diabetic rats with intact renal innervation enhanced CuU(Na)V after VE by 43 % (P < 0.001), while the combination of L-NAME and renal denervation restored CuU(Na)V to a value comparable to that of non-diabetic rats. In diabetic rats treated with either a relatively selective inhibitor for the neuronal isoform of NOS, 7-nitroindazole, or a relatively selective inhibitor for the inducible isoform of NOS, aminoguanidine, CuU(Na)V after VE was similar to the untreated diabetic rats irrespective of whether or not the renal nerves were present. This investigation demonstrated that NO production contributed, at least partly, to the depressed ability to excrete a saline load in diabetes mellitus. The endothelial isoform of NOS was most probably responsible for generating NO which caused the blunted excretory responses. The ability of NO to attenuate the excretory responses to volume expansion was an action independent of the renal innervation status. Experimental Physiology (2001) 86.4, 481-488.
No takes yet. Share an insight, caveat, or question.
Wongmekiat et al. (2001) studied Streptozotocin-induced diabetes. Nitric oxide synthase (NOS) inhibitors (L-NAME, 7-nitroindazole, aminoguanidine) vs. Untreated diabetic rats and non-diabetic rats was evaluated on Cumulative urine sodium excretion (CuU(Na)V) after volume expansion (p=<0.001). In diabetic rats, the non-selective NOS inhibitor L-NAME enhanced cumulative urine sodium excretion after volume expansion by 43% (P<0.001), suggesting endothelial NO blunts excretory responses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: